PRESS RELEASES

Year
November 23 | 2020
RAPT Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 16 | 2020
RAPT Therapeutics Reports Third Quarter 2020 Financial Results
November 16 | 2020
RAPT Therapeutics Reports Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
November 15 | 2020
RAPT Therapeutics to Announce Initial Data from Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
November 13 | 2020
RAPT Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
October 14 | 2020
RAPT Therapeutics Appoints Lisa Butterfield, Ph.D., and Lawrence Fong, M.D., to Scientific Advisory Board
September 03 | 2020
RAPT Therapeutics to Present at Upcoming Virtual Investor Conferences
August 13 | 2020
RAPT Therapeutics Reports Second Quarter 2020 Financial Results
August 05 | 2020
RAPT Therapeutics Appoints Phyllis Loud Gray as Vice President of Human Resources
June 18 | 2020
Peter Svennilson Elected to RAPT Therapeutics Board of Directors
June 17 | 2020
RAPT Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
May 29 | 2020
RAPT Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Virtual Scientific Program
May 26 | 2020
RAPT Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference
May 15 | 2020
RAPT Therapeutics Highlights Early Results for RPT193 at Society for Investigative Dermatology Meeting
May 14 | 2020
RAPT Therapeutics Reports First Quarter 2020 Financial Results
May 12 | 2020
RAPT Therapeutics to Present at the UBS Virtual Global Healthcare Conference
March 30 | 2020
RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update
March 04 | 2020
RAPT Therapeutics Announces Management Promotions
February 19 | 2020
RAPT Therapeutics Announces Upcoming Investor Conference Presentations
February 07 | 2020
RAPT Therapeutics Announces Pricing of $75 Million Public Offering
February 04 | 2020
RAPT Therapeutics Announces Proposed Offering of Common Stock
January 07 | 2020
RAPT Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference